Sitemap
Medical science
12/2001 Determination of Tumor Markers in Serum. Pitfalls and Good Practice
12/2001 Gas Chromatography-Mass Spectrometry Measurement of 6?-OH-Cortisol/Cortisol Ratio in Human Urine: A Specific Marker of Enzymatic Induction
12/2001 No Variation in Hsp70 mRNA Level during Cardiac Surgery in Pediatric Patients Evaluated by Semiquantitative RT-PCR
12/2001 Rapid Detection of Macroprolactin in tHe Form of Prolactin-Immunoglobulin G Complexes by Immunoprecipitation with Anti-human IgG-Agarose
12/2001 Molecular Characterization of Chromosome 22 Deletions by Short Tandem Repeat Polymorphism (STRP) in Patients with Conotruncal Heart Defects
12/2001 A Simple and Rapid Analysis of Triplet Repeat Diseases by Expand Long PCR
12/2001 The Effects of Peroxynitrite on Erythrocytes
12/2001 The Use of Hirudin as Universal Anticoagulant in Haematology, Clinical Chemistry and Blood Grouping
12/2001 Comparison of Different Immunoassays for CA 19-9
12/2001 The Evaluation of Analytical Performance of the Precision G Point-of-Care Glucometer
12/2001 On Painting and Philosophy: Sir Henry Raeburn
01/2002 Rationale for an oral thrombin inhibitor from a pharmacological point of view
01/2002 Anticoagulation: the present and the future
01/2002 The oral direct thrombin inhibitor Ximelagatran Prophylaxis of venous thromboembolism in hip and knee replacement
01/2002 Ximelagatran for treatment of venous thromboembolism
01/2002 New developments in anticoagulation therapy for Ione atrial fibrillation
01/2002 Future potential indications for an oral thrombin inhibitor
01/2002 Hirudins in the treatment of heparin-induced thrombocytopenia and in thrombosis prophylaxis
01/2002 Experimental and clinical results with the thrombin inhibitor Argatroban
01/2002 Bivalirudin, ein bivalentes, thrombinspezifisches Antikoagulans als Alternative zu Heparin bei Interventionen
01/2002 Treatment of superficial thrombophlebitis
01/2002 Diagnosis and therapy of thrombophlebitis with special consideration of low molecular weight heparin
01/2002 Prevention of catheter-induced thromboses by low molecular weight heparins
01/2002 Catheter-related thrombosis and its prevention in infancy
01/2002 Combination therapy with anticoagulants and platelet-active drugs
01/2002 The Upward Spiral of Drug Costs: A Time Series Analysis of Drugs Used in the Treatment of Hemophilia
01/2002 Cytokines in the Pathogenesis of Atherosclerosis
01/2002 Distribution of Th1- and Th2-induced Anti-factor VIII IgG Subclasses in Congenital and Acquired Hemophilia Patients
01/2002 The Thrombogram in Rare Inherited Coagulation Disorders: Its Relation to Clinical Bleeding
01/2002 Laboratory Diagnosis of Lupus Anticoagulants for Patients on Oral Anticoagulant Treatment
01/2002 Is APC Resistance a Risk Factor for Venous Thromboembolism in Patients over 70 Years?
01/2002 High Prevalence of Asymptomatic Deep Vein Thrombosis on Admission in a Medical Unit among Elderly Patients
01/2002 Clinical Use of a Rapid Collagen Binding Assay for von Willebrand Factor Cleaving Protease in Patients with Thrombotic Thrombocytopenic Purpura
01/2002 Effects of Transdermal and Oral Oestrogen Replacement Therapy on C-Reactive Protein Levels in Postmenopausal Women: A Randomised, Placebo-Controlled Trial
01/2002 Pseutarin C, a Prothrombin Activator from Pseudonaja textilis Venom: Its Structural and Functional Similarity to Mammalian Coagulation Factor Xa-Va Complex
01/2002 Anti-2-glycoprotein I Antibody-mediated Inhibition of Activated Protein C Requires Binding of 2-glycoprotein I to Phospholipids
01/2002 Recombinant Nematode Anticoagulant Protein c2, a Novel Inhibitor of Tissue Factor-Factor VIIa Activity, Abrogates Endotoxin-Induced Coagulation in Chimpanzees
01/2002 Protein C Deficiency caused by Homozygosity for a Novel PROC D180G Mutation - in vitro Expression and Structural Analysis of the Mutation
01/2002 The Endotoxin-induced Plasminogen Activator Inhibitor-1 Increase in Rabbits Is Not Tumor Necrosis Factor- Dependent and Can Occur in the Absence of Interleukin-1
01/2002 Does Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Contribute to Impairment of Fibrinolysis in Patients with Preeclampsia and/or Intrauterine Fetal Growth Retardation?
01/2002 Physical and Functional Interaction Between Cell-Surface Calreticulin and the Collagen Receptors Integrin 21 and Glycoprotein VI in Human Platelets
01/2002 Analysis of the Amino Acid Requirement for a Normal IIb3 Maturation at IIbGlu324 Commonly Mutated in Glanzmann Thrombasthenia
01/2002 Induction of Vasoactive Substances Differs in LPS-Induced and TF-Induced DIC Models in Rats
01/2002 Aurintricarboxylic Acid Attenuates Intimal Thickening after Balloon Injury of the Rabbit Aorta
01/2002 The Mucin-like Macroglycopeptide Region of Glycoprotein Ib is Required for Cell Adhesion to Immobilized von Willebrand Factor (VWF) Under Flow but not for Static VWF Binding
01/2002 Erythropoietin Triggers a Signaling Pathway in Endothelial Cells and Increases the Thrombogenicity of their Extracellular Matrices In Vitro
01/2002 Standardisation of von Willebrand Factor in Therapeutic Concentrates: Calibration of the 1st International Standard for von Willebrand Factor Concentrate (00/514)
01/2002 Venous Thrombosis Following the Use of Intermediate Purity FVIII Concentrate to Treat Patients with Von Willebrand's Disease
01/2002 The Diagnostic Value of Compression Ultrasonography in Patients with Suspected Recurrent Deep Vein Thrombosis
01/2002 Comparison of Outcomes after Hospitalization for Deep Venous Thrombosis or Pulmonary Embolism
01/2002 Enhanced Coagulation Activation in Preeclampsia: the Role of APC Resistance, Microparticles and Other Plasma Constituents
01/2002 Von Willebrand's Disease caused by Compound Heterozygosity for a Substitution Mutation (T1156M) in the D3 Domain of the Von Willebrand Factor and a Stop Mutation (Q2470X)
01/2002 Novel Fibrinogen Truncation with Deletion of B Chain Residues 440-461 causes Hypofibrinogenaemia
01/2002 The Structure of Synthetic Oligosaccharides in Relation to Factor IXa Inhibition
01/2002 Antithrombin DREUX (Lys114Glu): A Variant with Complete
Loss of Heparin Affinity
01/2002 Reduced Factor V Concentration and Altered FV1/FV2 Ratio do not fully Explain R2-associated APC-resistance
01/2002 Expression and Characterization of Recombinant Murine Factor VIII
01/2002 A Reassessment of the Relationship between International Reference Preparations for Human and Rabbit Thromboplastins
01/2002 Mice with a Severe Deficiency of the Endothelial Protein C Receptor Gene Develop, Survive, and Reproduce Normally, and Do not Present with Enhanced Arterial Thrombosis after Challenge
01/2002 Role of Microthrombus Formation in the Development of Ischemia/Reperfusion-induced Liver Injury in Rats
01/2002 Relationships between Fibrinolytic and Inflammatory Parameters in Human Adipose Tissue: Strong Contribution of TNF Receptors to PAI-1 Levels
01/2002 Inhibition of ADP-induced P-selectin Expression and Platelet-Leukocyte Conjugate Formation by Clopidogrel and the P2Y12 Receptor Antagonist AR-C69931MX but not Aspirin
01/2002 Effects of Enhanced P2X1 Receptor Ca2+ Influx on Functional Responses in Human Platelets
01/2002 Two New 3 Integrin Mutations in Indian Patients with Glanzmann Thrombasthenia: Localization of Mutations Affecting Cysteine Residues in Integrin 3
01/2002 Collagen Response and Glycoprotein VI Function Decline Progressively as Canine Platelets Age in vivo
01/2002 Platelet Associated u-PA Up-regulates u-PA Synthesis by Endothelial Cells
01/2002 15-Deoxy-12,14-Prostaglandin J2 Inhibits Tissue Factor Expression in Human Macrophages and Endothelial Cells: Evidence for ERK1/2 Signaling Pathway Blockade
01/2002 Growing Significance of Myeloperoxidase in Non-infectious Diseases
01/2002 Serum Paraoxonase Activity and the Extent of
Lipid Peroxidation Are not Affected by Increased Levels of Human Apolipoprotein A-I: Studies in Transgenic Mice
01/2002 Relationship between the Sialic Acid Content of Low-Density Lipoprotein (LDL) and Autoantibodies to Oxidized LDL in the Plasma of Healthy Subjects and Patients with Atherosclerosis
Back
Search
